Letrozole 2.5 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB25FLUWY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,501
Award facts
- Contract value 100% obligated
- $5,500.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 24, 2025, for the supply of Letrozole 2.5 mg tablets in quantities of 90 tablets at a ceiling value of $5,500.60. This delivery order is structured as a firm fixed price contract with no set-aside designation, indicating it was competitively awarded. The ultimate completion date is set for April 25, 2025, and the place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a continuation of the company's role as a critical pharmaceutical supplier to federal military and healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a total contract value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Letrozole, an aromatase inhibitor used primarily in cancer treatment, falls within the broad therapeutic domains covered under the company's federal medical supply portfolio. AmerisourceBergen Drug Corp's sustained awards through this vehicle demonstrate its capability to meet federal pharmaceutical procurement requirements through open competition and its established position as a major healthcare solutions provider for the Department of Defense.
Quick answers
Who was awarded contract SPE2DB25FLUWY?
SPE2DB25FLUWY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on April 24, 2025.
How much is contract SPE2DB25FLUWY worth?
The government has obligated $5,501 on SPE2DB25FLUWY.
Is contract SPE2DB25FLUWY an order under another contract?
Yes. SPE2DB25FLUWY is a delivery order under SPE2DB22D6029, an indefinite delivery contract.
Was contract SPE2DB25FLUWY competed?
The extent of competition for SPE2DB25FLUWY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award